Srivastava P, Kaeda J S, Roper D, Vulliamy T J, Buckley M, Luzzatto L
Department of Hematology, Burton Hospitals NHS Trust, Burton on Trent, UK.
Blood. 1995 Sep 1;86(5):1977-82.
We have investigated a 13-year-old girl from first cousin parents who presented with severe hemolytic anemia. Hematologic studies showed unstable hemoglobin (Hb) disease (chronic Heinz body anemia), and DNA analysis showed that the patient was homozygous for the previously reported abnormal Hb called Hb Bushwick (beta 74E18 gly-->val). Hb Bushwick is unstable in vitro and in vivo. In addition, using globin chain biosynthetic studies, we show that the beta (Bushwick) chains are unstable. Six members of the patient's family were heterozygous for Hb Bushwick and had a compensated hemolytic disorder. By contrast, the homozygous patient had chronic anemia caused by a combination of hemolysis and ineffective erythropoiesis that was subject to severe exacerbation concomitant with infection. Thus, although unstable Hb disease is correctly regarded as dominant, we clearly see a dosage effect in its expression, whereby the homozygous state is still compatible with life although the red blood cells contain nearly 100% unstable Hb.
我们对一名来自近亲父母的13岁女孩进行了研究,她患有严重的溶血性贫血。血液学研究显示为不稳定血红蛋白(Hb)病(慢性海因茨小体贫血),DNA分析表明该患者对于先前报道的异常血红蛋白Hb Bushwick(β74E18甘氨酸→缬氨酸)呈纯合状态。Hb Bushwick在体外和体内均不稳定。此外,通过珠蛋白链生物合成研究,我们发现β(Bushwick)链不稳定。该患者家族中的六名成员为Hb Bushwick杂合子,患有代偿性溶血性疾病。相比之下,该纯合患者患有由溶血和无效红细胞生成共同导致的慢性贫血,在感染时会严重加重。因此,尽管不稳定Hb病被正确地视为显性疾病,但我们清楚地看到其表达存在剂量效应,即尽管红细胞中几乎含有100%的不稳定Hb,但纯合状态仍可存活。